The Use of Pharmacogenomics for Selection of Therapy in Non-Small-Cell Lung Cancer

机译：药物基因组学在非小细胞肺癌治疗选择中的应用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

INTRODUCTIONPerformance status (PS) is the only known clinical predictor of outcome in patients with advanced non-small-cell lung cancer (NSCLC), although pharmacogenomic markers may also correlate with outcome. The aim of our study was to correlate clinical and pharmacogenomic measures with overall survival.

机译：前言尽管晚期基因组学指标可能与预后相关，但绩效状态（PS）是晚期非小细胞肺癌（NSCLC）患者预后的唯一临床预后指标。我们研究的目的是将临床和药物基因组学措施与总生存期相关联。

著录项

期刊名称 Clinical Medicine Insights. Oncology
作者
Nagla A Karim; Hai Bui; Peterson Pathrose; Sandra Starnes; Ninad Patil; Mahmoud Shehata; Ahmed Mostafa; MB Rao; Ahmad Zarzour; Marshall Anderson;
展开▼
作者单位

展开▼
年(卷),期 2014(8),-1
年度 2014
页码 139–144
总页数 6
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
pharmacogenomics selection of therapy non-small-cell lung cancer;

机译：药物基因组学;治疗选择;非小细胞肺癌;

相似文献

外文文献
中文文献
专利

1. The Use of Pharmacogenomics for Selection of Therapy in Non-Small-Cell Lung Cancer [J] . Nagla A. Karim, Hai Bui, Peterson Pathrose, Clinical Medicine Insights: Oncology . 2014,第8期

机译：药物基因组学在非小细胞肺癌治疗选择中的应用
2. Pharmacogenomics in non-small-cell lung cancer chemotherapy. [J] . Danesi R, Pasqualetti G, Giovannetti E Advanced drug delivery reviews . 2009,第5期

机译：药物基因组学在非小细胞肺癌化疗中的应用。
3. The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer. [J] . Carlson JJ, Garrison LP, Ramsey SD, Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2009,第1期

机译：EGFR基因组酪氨酸激酶抑制剂治疗非小细胞肺癌的药物基因组学方法的潜在临床和经济结果。
4. CT image fusion in the optimization of replanning during the course of 3-dimensional conformal radiotherapy for non-small-cell lung cancer [C] . Xu XiMing, Deng JunJian, Guo HongTing, 2010 3rd International Conference on Biomedical Engineering and Informatics . 2010

机译：非小细胞肺癌3D立体适形放疗过程中CT图像融合对重新计划的优化
5. Use of Palliative Radiotherapy Among Metastatic Non-small-cell Lung Cancer (NSCLC) Patients in Puerto Rico [D] . ?Quinones Avila, Valerie 2020

机译：在波多黎各的转移性非小细胞肺癌（NSCLC）患者中使用姑息放射治疗
6. Immunohistochemical Characterization of Three Monoclonal Antibodies Raised against the Epidermal Growth Factor and Its Receptor in Non-Small-Cell Lung Cancer: Their Potential Use in the Selection of Patients for Immunotherapy [O] . Charles E. Rengifo, Rancés Blanco, Damián Blanco, 2013

机译：在非小细胞肺癌中针对表皮生长因子及其受体的三种单克隆抗体的免疫组织化学表征：其在选择免疫治疗患者中的潜在用途
7. Corrigendum to “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis” Lung Cancer, Volume 130 (April) (2019) 162–168 [O] . Corey C. Foster, Chad G. Rusthoven, David J. Sher, 2019

机译：勘探为“早期非小细胞肺癌的立体定向体放射疗法后辅助化疗与较低的整体生存率相关：国家癌症数据库分析”肺癌，第130卷（四月）（2019）（2019）162-168
8. Pharmacogenomic Strategies to Refine Cisplatin Therapy in Lung Cancer [R] . Stevenson, M. 2010

机译：改善顺铂治疗肺癌的药物基因组学策略

The Use of Pharmacogenomics for Selection of Therapy in Non-Small-Cell Lung Cancer

摘要

著录项

相似文献

相关主题

期刊订阅